{
    "clinical_study": {
        "@rank": "139470", 
        "arm_group": {
            "arm_group_label": "non-interventional", 
            "description": "non-interventional"
        }, 
        "brief_summary": {
            "textblock": "This single center study will monitor the developmental progress of PPHN patients who\n      received iv sildenafil in study A1481276.  Two visits will be conducted, at 12 and 24 months\n      following the end of study drug infusion."
        }, 
        "brief_title": "A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Pulmonary Hypertension, Persistent, of the Newborn", 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Hypertension, Pulmonary", 
                "Persistent Fetal Circulation Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will monitor developmental progress of PPHN patients for 2 years following study\n      treatment, using Bayley III and Hammersmith tools. Data will be explored with descriptive\n      statistics."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Any subject who received sildenafil treatment in study A1481276.\n\n          -  Signed and dated informed consent document by legal guardian.\n\n        Exclusion Criteria:\n\n          -  Any subject who did not receive sildenafil treatment during study A1481276."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "14 Months", 
            "minimum_age": "10 Months", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Pediatric patients who took part in study A1481276 following PPHN treatment with IV\n        sildenafil"
            }
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01801982", 
            "org_study_id": "A1481283"
        }, 
        "intervention": {
            "arm_group_label": "non-interventional", 
            "description": "non-interventional", 
            "intervention_name": "non-interventional", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Sildenafil"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "PPHN; development progress after PPHN; developmental progress after sildenafil.", 
        "lastchanged_date": "May 14, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1481283&StudyName=A%20Non-Interventional%20Follow%20Up%20Study%20For%20Subjects%20Who%20Received%20Sildenafil%20for%20Persistent%20Pulmonary%20Hypertension%20of%20the%20Newborn%20%28PPHN%29"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom", 
                    "zip": "WC1N 3JH"
                }, 
                "name": "Great Ormond Street Hospital, Paediatric Intensive Care"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Follow Up Investigation For Patients Completing Study A1481276 To Investigate Developmental Progress 12 And 24 Months Following Completion Of Sildenafil Treatment", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Developmental progress", 
                "measure": "Physical Examination (Bayley Neurological Assessments, Ophthalmology Exam, Hearing)", 
                "safety_issue": "No", 
                "time_frame": "at 12 months"
            }, 
            {
                "description": "Developmental progress", 
                "measure": "Physical Examination (Bayley Neurological Assessments, Ophthalmology Exam, Hearing)", 
                "safety_issue": "No", 
                "time_frame": "at 24 months"
            }, 
            {
                "description": "Hearing test to be conducted by HCP", 
                "measure": "Medical History, to include clinically relevant hospital admissions", 
                "safety_issue": "No", 
                "time_frame": "at 12 months"
            }, 
            {
                "description": "Hearing test to be conducted by HCP", 
                "measure": "Medical History, to include clinically relevant hospital admissions", 
                "safety_issue": "No", 
                "time_frame": "at 24 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01801982"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "safety", 
                "measure": "Overall Survival (OS)", 
                "safety_issue": "Yes", 
                "time_frame": "at 12 months"
            }, 
            {
                "description": "safety", 
                "measure": "Overall Survival (OS)", 
                "safety_issue": "Yes", 
                "time_frame": "at 24 months"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}